本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

20.93
-1.3000-5.85%
成交量:165.82万
成交额:3,536.00万
市值:18.45亿
市盈率:-4.78
高:22.82
开:22.04
低:20.79
收:22.23
52周最高:47.65
52周最低:20.79
股本:8,815.85万
流通股本:6,602.58万
量比:2.61
换手率:2.51%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
净资产收益率:-80.88%
总资产收益率:-46.18%
市净率:3.35
市盈率(LYR):-9.14

数据加载中...

2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities